Puma Biotechnology, Inc. (PBYI)

NASDAQ: PBYI · Real-Time Price · USD

7.17

-0.07 (-0.97%)

At close: May 29, 2026, 4:00 PM EDT

7.03

-0.14 (-1.95%)

After-hours: May 29, 2026, 6:34 PM EDT

Puma Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	227.18	228.37	230.47	235.64	228.03	253.16
Revenue Growth (YoY)	-2.38%	-0.91%	-2.19%	3.34%	-9.92%	12.46%
Cost of Revenue	58.03	58.16	64.4	62.68	55.09	63.7
Gross Profit	169.15	170.21	166.06	172.96	172.94	189.45
Selling, General & Admin	71.67	70.85	80.16	89.93	89.98	116.29
Research & Development	68	62.07	54.94	50.38	52.24	71.87
Other Operating Expenses	-	-	-	-	7	-
Total Operating Expenses	139.67	132.92	135.1	140.32	149.22	188.16
Operating Income	29.49	37.3	30.97	32.64	23.72	1.29
Interest Income	3.98	4.08	4.72	2.61	0.81	0.16
Interest Expense	-5.18	-6.62	-12.45	-13.33	-11.59	-12.81
Other Non-Operating Income (Expense)	0.8	1.03	0.86	0.76	-12.48	-17.45
Total Non-Operating Income (Expense)	-0.4	-1.52	-6.87	-9.97	-23.26	-30.09
Pretax Income	29.09	35.78	24.1	22.67	0.46	-28.8
Provision for Income Taxes	4.76	4.67	-6.18	1.08	0.46	0.32
Net Income	24.38	31.11	30.28	21.59	0	-29.13
Net Income to Common	24.38	31.11	30.28	21.59	0	-29.13
Net Income Growth	-35.95%	2.75%	40.23%	1079450.00%	-	-
Shares Outstanding (Basic)	50	50	49	47	45	41
Shares Outstanding (Diluted)	51	51	49	48	45	41
Shares Change (YoY)	3.38%	3.16%	3.26%	5.83%	10.56%	2.69%
EPS (Basic)	0.50	0.62	0.62	0.46	-	-0.72
EPS (Diluted)	0.48	0.61	0.62	0.45	-	-0.72
EPS Growth	-37.66%	-1.61%	37.78%	-	-	-
Shares Outstanding	50.88	50.41	49.11	47.65	46.35	41.18
Free Cash Flow	53.6	41.73	38.86	26.87	-15.83	20.65
Free Cash Flow Growth	28.43%	7.38%	44.64%	-	-	2740.44%
Free Cash Flow Per Share	1.05	0.82	0.79	0.57	-0.35	0.51
Gross Margin	74.46%	74.53%	72.06%	73.40%	75.84%	74.84%
Operating Margin	12.98%	16.33%	13.44%	13.85%	10.40%	0.51%
Profit Margin	10.73%	13.62%	13.14%	9.16%	0.00%	-11.51%
FCF Margin	23.59%	18.27%	16.86%	11.40%	-6.94%	8.16%
EBITDA	40.21	48.24	42.49	44.16	33.56	12.6
EBITDA Margin	17.70%	21.12%	18.44%	18.74%	14.72%	4.98%
EBIT	29.49	37.3	30.97	32.64	23.72	1.29
EBIT Margin	12.98%	16.33%	13.44%	13.85%	10.40%	0.51%
Effective Tax Rate	16.36%	13.05%	-25.63%	4.78%	99.56%	-1.12%

SEC Filings: 10-K · 10-Q